Le facteur VII activé recombinant: un nouveau traitement de l'hémophilie

This publication has 11 references indexed in Scilit:

• Platelet activity of high‐dose factor VIIa is independent of tissue factor
  British Journal of Haematology, 1997
• Feasibility of Using Recombinant Factor VIIa in Continuous Infusion
  Thrombosis and Haemostasis, 1996
• Pharmacokinetics and pharmacodynamics of recombinant factor VIIa
  Clinical Pharmacology & Therapeutics, 1994
• Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa)
  Blood Coagulation & Fibrinolysis, 1993
• Mechanism by which recombinant factor VIIa shortens the aPTT: Activation of factor X in the absence of tissue factor
  Thrombosis Research, 1989
• Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor
  American Journal of Hematology, 1989
• Extrinsic Coagulation Pathway Inhibitor during Recombinant Factor VIIa Infusion
  Thrombosis and Haemostasis, 1989
• SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMY
  The Lancet, 1988
• Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells
  Biochemistry, 1988
• Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.
  Journal of Clinical Investigation, 1983